UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-QSB

(Mark One)

 

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

For the quarterly period ended September 30, 2005

 

 

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period from                   to                 .

 

Commission file number 000-30656

 

APOGEE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

04-3005815

(State or other jurisdiction of
incorporation or organization)

(IRS Employer Identification No.)

 

129 MORGAN DRIVE, NORWOOD, MASSACHUSETTS 02062 00000

(Address of principal executive offices)

 

(781) 551-9450

(Issuer’s telephone number, including area code)

 

 

NOT APPLICABLE.

(Former name, former address and former fiscal year,

if changed since last report)

 

Check whether the issuer: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes ý No o

 

Transitional Small Business Disclosure Format (Check one):   Yes o No ý

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes o No ý

 

State the number of shares of each of the Issuer’s classes of common equity, as of the latest practicable date:  As of November 4, 2005, there were 11,968,332 shares of Common Stock, $.01 par value per share, outstanding.

 

 

 

 

 



 

APOGEE TECHNOLOGY, INC.

 

INDEX OF INFORMATION CONTAINED IN FORM 10-QSB FOR THE

QUARTER ENDED SEPTEMBER 30, 2005 AND RESTATED SEPTEMBER 30, 2004

 

 

 

 

 

PAGE

PART I-FINANCIAL INFORMATION

 

 

 

 

 

Item 1 - Financial Statements

 

 

Condensed Consolidated Balance Sheets at September 30, 2005 (all unaudited) and December 31, 2004 (audited)

3

 

Condensed Consolidated Statements of Operations and Accumulated Deficit for the Three and Nine Months Ended September 30, 2005 and restated September 30, 2004 (all unaudited)

4

 

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2005 and restated September 30, 2004 (all unaudited)

5

 

Notes to Condensed Consolidated Financial Statements (all unaudited)

6

 

 

 

 

Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

 

 

 

 

Item 3 - Quantitative and Qualitative Disclosures about Market Risk

33

 

 

 

 

Item 4 - Controls and Procedures

33

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

 

Item 1 - Legal Proceedings

33

 

 

 

 

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

34

 

 

 

 

Item 3 - Defaults Upon Senior Securities

34

 

 

 

 

Item 4 - Submission of Matters to a Vote of Security Holders

34

 

 

 

 

Item 5 - Other Information

34

 

 

 

 

Item 6 - Exhibits

34

 

 

 

 

Signatures

35

 

 

2



 

 

 

APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

 

 

 

September 30,

 

DECEMBER 31,

 

 

 

2005

 

2004

 

 

 

(Unaudited)

 

(Audited)

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

812,485

 

$

1,886,883

 

Accounts receivable, net of allowance for doubtful accounts of $145,000 and $105,000, respectively

 

465,456

 

533,113

 

Inventories, net

 

1,751,900

 

2,725,308

 

Deferred costs other

 

367,525

 

 

Deferred note financing costs

 

306,000

 

 

Prepaid expenses and other current assets

 

61,956

 

252,728

 

Total current assets

 

3,765,322

 

5,398,032

 

Property and equipment, net of accumulated depreciation of $427,240 and $376,951, respectively

 

116,526

 

103,189

 

Other assets

 

 

 

 

 

Patent, net of accumulated amortization of $147,206 and $127,442, respectively

 

266,387

 

211,901

 

 

 

$

4,148,235

 

$

5,713,122

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable and accrued expenses

 

$

1,705,754

 

$

1,107,111

 

Deferred distributor revenue

 

1,724,009

 

1,955,563

 

Note payable other

 

2,000,000

 

 

Notes payable Officer and shareholder

 

500,000

 

 

Advances

 

205,000

 

 

Deferred contract revenue

 

72,686

 

95,788

 

Total current liabilities

 

6,207,449

 

3,158,462

 

Commitments and Contingencies

 

 

 

Stockholders' equity (deficiency)

 

 

 

 

 

Common stock, $.01 par value; 20,000,000 shares authorized, 11,838,332 issued and outstanding at September 30, 2005 and December 31, 2004

 

118,383

 

118,383

 

Additional paid-in capital

 

18,073,223

 

18,073,223

 

Accumulated deficit

 

(20,250,821

)

(15,636,946

)

Total stockholders' equity (deficiency)

 

(2,059,215

)

2,554,660

 

 

 

$

4,148,235

 

$

5,713,122

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

3



 

APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

 

 

 

THREE MONTHS ENDED

 

NINE MONTHS ENDED

 

 

 

September, 30

 

September, 30

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

Product sales

 

$

1,157,789

 

$

1,388,132

 

$

3,326,238

 

$

3,926,841

 

Royalties

 

212,397

 

446,415

 

473,328

 

890,388

 

Consulting

 

150,000

 

161,270

 

150,000

 

665,754

 

 

 

1,520,186

 

1,995,817

 

3,949,566

 

5,482,983

 

Costs and expenses

 

 

 

 

 

 

 

 

 

Product sales

 

1,122,084

 

1,153,299

 

2,975,312

 

3,240,038

 

Research and development

 

785,403

 

664,032

 

2,308,410

 

1,982,625

 

Selling, general and administrative

 

1,158,569

 

632,733

 

3,251,653

 

1,905,500

 

 

 

3,066,056

 

2,450,064

 

8,535,375

 

7,128,163

 

Operating loss

 

(1,545,870

)

(454,247

)

(4,585,809

)

(1,645,180

)

Other (expense) income

 

 

 

 

 

 

 

 

 

Interest/finance expense

 

(35,552

)

 

(38,930

)

 

Interest income

 

4,814

 

5,365

 

10,865

 

16,249

 

 

 

(30,738

)

5,365

 

(28,065

)

16,249

 

Net loss

 

(1,576,608

)

(448,882

)

(4,613,874

)

(1,628,931

)

Accumulated deficit - beginning

 

(18,674,212

)

(13,431,796

)

$

(15,636,946

)

$

(12,251,748

)

Accumulated deficit - ending

 

$

(20,250,820

)

$

(13,880,678

)

$

(20,250,820

)

$

(13,880,678

)

Basic and diluted loss per common share

 

$

(0.13

)

$

(0.06

)

$

(0.39

)

$

(0.14

)

Weighted average common shares outstanding - basic and diluted

 

11,838,332

 

11,566,166

 

11,838,332

 

11,438,871

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

4



 

APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

 

 

 

NINE MONTHS ENDED

 

 

 

September 30,

 

 

 

2005

 

2004

 

 

 

 

 

(Restated)

 

Cash flows from operations

 

 

 

 

 

Net loss

 

$

(4,613,874

)

$

(1,628,931

)

Adjustments to reconcile net (loss) income to net cash used in operating activities:

 

 

 

 

 

Provision for doubtful accounts

 

40,000

 

15,000

 

Provision for slow moving, excess and obsolete inventory

 

576,238

 

420,421

 

Depreciation and amortization

 

70,053

 

74,716

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

27,656

 

754,058

 

Inventories

 

397,171

 

(800,494

)

Prepaid expenses and other current assets

 

190,774

 

(40,389

)

Accounts payable and accrued expenses

 

598,643

 

40,211

 

Deferred note financing costs

 

(367,525

)

 

Deferred note other

 

(306,000

)

 

Deferred product revenue

 

(231,554

)

(604,677

)

Deferred contract revenue

 

(23,103

)

45,788

 

Net cash used in operating activities

 

(3,641,521

)

(1,724,297

)

Cash flows from investing activities

 

 

 

 

 

Purchases of property and equipment

 

(63,626

)

(42,614

)

Patent costs

 

(74,251

)

(38,803

)

Other intangible assets

 

 

(114,056

)

Net cash used in investing activities

 

(137,877

)

(195,473

)

Cash flows from financing activities

 

 

 

 

 

Proceeds from issuances of common stock

 

 

1,906,899

 

Proceeds from loan

 

2,000,000

 

 

Proceeds from officer loan

 

250,000

 

 

Proceeds from shareholder loan

 

250,000

 

 

Proceeds from Advance

 

205,000

 

 

Net cash provided by financing activities

 

2,705,000

 

1,906,899

 

Decrease in cash and cash equivalents

 

(1,074,398

)

(12,871

)

Cash and cash equivalents - beginning

 

1,886,883

 

2,524,209

 

Cash and cash equivalents - ending

 

$

812,485

 

$

2,511,338

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

5


 


APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2005 AND RESTATED SEPTEMBER 30, 2004

 

1.             The Company and Basis of Presentation

 

The Company

 

Apogee Technology, Inc. and Subsidiary (the “Company” or “Apogee”) designs, develops and markets silicon based products incorporating proprietary technologies.  The Company historically owned, developed and marketed patented all-digital, high efficiency Direct Digital Amplification (DDX®) technology Integrated Circuits (“ICs”) which are used in a range of audio applications, including:  home theater systems, powered speakers, car audio, commercial audio, and PC multi-media. On October 5, 2005 the Company sold its audio business through the sale of certain assets and, in particular, its DDX technology to SigmaTel, Inc. as detailed in Note 13 — Subsequent Events and as a result has discontinued its audio division. The Company is developing new system-on-chip products using its analog and digital circuit designs and Micro-Electromechanical Systems (“MEMS”) technology for the consumer, automotive, industrial and medical markets.

 

Basis of Presentation

 

The financial statements include the accounts of Apogee Technology, Inc., and its wholly owned inactive subsidiary, DUBLA, Inc. All significant intercompany transactions and accounts have been eliminated.

 

In the opinion of the Company’s management, all adjustments, consisting of normal recurring accruals considered necessary for a fair presentation, have been included in the accompanying unaudited financial statements.  Operating results for the nine months ended September 30, 2005 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2005.

 

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods and such differences could be material.

 

Liquidity

 

The Company’s consolidated financial statements have been prepared assuming the Company will continue as a going concern.  Because the Company has had recurring losses and at September 30, 2005 has deficiencies of working capital and stockholders’ equity of approximately $2.4 million and $2.0 million, respectively.  Subsequent to September 30, 2005, the Company sold for $9.4 million certain assets and its DDX technology to SigmaTel, Inc.  The Company believes that its working capital will be sufficient to fund its capital and operational requirements at least through 2006.  See Subsequent Events - Note 13.

 

The long term success of the Company is dependent upon its ability to successfully develop and market its MEMS technology and raise additional funds if needed for such purpose.  There can be no assurance, however, that the Company will be able to raise the funds that it needs to continue its operations or that additional funds will be available to the Company on acceptable terms, if at all.

 

In May 2005, the Company received proceeds from unsecured interest-bearing loans in the amounts of $250,000 from David Spiegel, a shareholder and $250,000 from Herbert Stein, Chief Executive Officer, President and Chairman of the Board.  These loans were payable upon demand and were not subject to any premium or penalty for prepayment.

 

6



 

The loan interest rate was 6% per annum, payable monthly in arrears on the outstanding balance.   On October 20, 2005 proceeds from the SigmaTel transaction were used to repay the $500,000 principal as well as all accrued interest. See Subsequent Events - Note 13.

 

On August 11, 2005, the Company entered into agreements with Laurus Master Fund, Ltd. (“Laurus”), whereby the Company received $2.0 million in gross proceeds (with net proceeds of approximately $1.8 million) through the sale of a 120 day secured term note. In accordance with the terms of the note, the note was payable by the Company in cash during the first 120 days following the issuance of the note, and after the 120 day period it was payable in the amount of $62,500 per month in cash or convertible into the common stock, $0.01 par value per share, of the Company at a fixed conversion price of $1.05 per share. In connection with the financing, the Company paid certain costs and expenses of Laurus and has issued an immediately exercisable warrant with terms restricting exercise. The Laurus warrant provides for the purchase of 85,000 shares of common stock at a price of $1.22 per share. The warrant expires seven years after issuance. A finder for the transaction has received a fee of 5% of the gross proceeds of the offering, together with a seven year warrant to purchase an aggregate of 8,500 shares of common stock immediately exercisable at a price of $1.22 per share. This offering was conducted as a private placement pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. With respect to the transaction with Laurus, the Company has entered into an agreement to register the common stock underlying the warrants and the common stock that may be received upon any conversion of the secured term note.  On October 5, 2005 proceeds from the SigmaTel transaction were used to repay in full $2.1 million owed to Laurus Master Fund, Ltd.  See Subsequent Events — Note 13.

 

2.         Summary of Significant Accounting Policies

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 (“SAB 104”), “Revenue Recognition in Financial Statements: Revenue Recognition”, which states that revenue should be recognized when the following revenue recognition criteria are met:  (1) persuasive evidence of an arrangement exists; (2) the product has been shipped and the customer takes ownership and assumes the risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured.  The following policies apply to the Company’s major product sales categories for revenue recognition.

 

Sales to OEM Customers:  Revenue is recognized under the Company’s standard terms and conditions of sale, title and risk of loss transfer to the customer at the time products are shipped to the customer or the customers’ representative/freight forwarder (shipping terms Ex Works).  The Company has experienced minimal warranty or other returns and based upon historical experience, has recorded a $10,000 provision for such returns.

 

Sales to Distributors:  At certain times the Company provides incentives such as stock rotation, price protection and other incentives to its Distributors.  Therefore, under the sell through method of revenue recognition the Company defers recognition of revenue until such time that the distributor sells products to its customers based upon receipt

 

7



 

 

of point-of-sale reports from the distributors. Distributor payments received before revenue is recognized is recorded as deferred revenue.  Unsold inventory held at distributors is included as a component of finished goods inventory.   See Note 12 on the Company’s adoption of the sell through method.

 

In addition, the Company records royalty revenue when earned in accordance with the underlying agreements, which are based upon sales of products commercialized from the Company’s licensed technology. Consulting revenue is recognized as services are performed in accordance with the terms of the underlying consulting agreements.

 

Loss Per Share

 

Basic loss per share is computed by dividing the net loss attributable to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period.  Diluted net loss per share is computed based on the weighted average number of shares of common stock and shares of common stock issuable upon the exercise of stock options and common stock warrants.

 

Research and Development

 

Costs for research and development are expensed as incurred.

 

Inventories

 

Inventories, including inventory held at distributors (See Note 4) are stated at the lower of cost on a first-in, first-out basis or market.  This policy requires the Company to make estimates regarding the market value of the Company’s inventory, including an assessment of excess or obsolete inventory.  The Company determines excess and obsolete inventory based on an estimate of the future demand and estimated selling prices for the Company’s products within a specified time horizon, generally 12 to 24 months. The estimates the Company uses for expected demand are also used for near-term capacity planning and inventory purchasing and are consistent with the Company’s revenue forecasts.  Actual demand and market conditions may differ from those projected by the Company’s management.

 

If the Company’s unit demand forecast is less than the Company’s current inventory value, the Company will be required to take additional excess inventory charges or write-downs to net realizable value which will decrease the Company’s gross margin and net operating results in the future.  During the three and nine months ended September 30, 2005, the Company recorded a provision for inventory losses of approximately $255,000 and $576,000, respectively, to account for slow moving, excess and obsolete inventory, including inventories to be delivered on non-cancelable purchase commitments.

 

Purchase commitment losses

 

The Company accrues for estimated losses on non-cancelable purchase orders.  The estimated losses result from anticipated future sale of products for sales prices less than the estimated cost to manufacture.  For the nine months ended September 30, 2005, the Company has allocated approximately $400,000 of the total $1.7 million of excess inventory and obsolescence reserve against non-cancelable purchase commitments of approximately $1.2 million at September 30, 2005.  There was no such allocation at September 30, 2004.

 

 

8



 

 

Property and Equipment

 

Major replacements and betterments of equipment are capitalized.  Cost of normal maintenance and repairs is charged to expense as incurred.  Depreciation is provided over the estimated useful lives of the assets using accelerated methods.  Leasehold improvements are amortized over either the term of lease or the estimated useful life of the improvement.

 

Patents

 

Costs incurred to register and obtain patents are capitalized and amortized on a straight-line basis over five years, their estimated useful lives.

 

Use of Estimates in Financial Statements

 

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

The Company carries its accounts receivable from direct customers at cost less an allowance for doubtful accounts to ensure that trade receivables are carried at net realizable value.  On a periodic basis, the Company evaluates the collectibility of its accounts receivable on a variety of factors, including length of time receivables are past due, indication of customer willingness to pay, significant one-time events and historical experience. An additional reserve for individual accounts is recorded when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy filings or substantial deterioration in the customer’s operating results or financial position. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.  Accounts receivable are generally considered past due if any portion of the receivable balance is outstanding for more than 90 days.   If circumstances related to the Company’s customers change, estimates of the recoverability of receivables would be further adjusted.

 

Fair value of financial instruments

 

Carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and notes and accounts payable, approximate their fair values due to their relative short maturities and based upon comparable market information available at the respective balance sheet dates. The Company does not hold or issue financial instruments for trading purposes.

 

 

9



 

3.         Pro-forma Information — Stock Options

 

The Company has adopted only the disclosure provisions of Financial Accounting Standard No. 123, “Accounting For Stock-Based Compensation” (FAS 123).  It applies APB Opinion No. 25, “Accounting For Stock Issued To Employees”, and related interpretations in accounting for its stock-based compensation plan and does not recognize compensation expense for this plan other than for certain options granted in 2001.

 

The following tables illustrate the effect on net loss and loss per share if the Company had applied the fair value recognition provisions of FAS 123 to stock-based employee compensation.

 

 

 

 

Nine Months Ended

 

 

 

September 30, (Unaudited)

 

 

 

2005

 

2004

 

 

 

 

 

(Restated)

 

 

 

 

 

 

 

Net loss, as reported

 

$

(4,613,874

)

$

(1,628,930

)

 

 

 

 

 

 

Deduct:  Total stock-based employee compensation expense determined under fair value based method for all awards *

 

(1,509,818

)

(3,782,346

)

 

 

 

 

 

 

Pro-forma net loss **

 

$

(6,123,692

)

$

(5,411,276

)

Loss per share:

 

 

 

 

 

 

 

 

 

 

 

As reported, basic and diluted

 

$

(0.39

)

$

(0.14

)

 

 

 

 

 

 

Pro-forma, basic and diluted

 

$

(0.52

)

$

(0.47

)

 

 

 

 

Three Months Ended

 

 

 

September 30, (Unaudited)

 

 

 

2005

 

2004

 

 

 

 

 

(Restated)

 

Net loss, as reported

 

$

(1,576,608

)

$

(448,882

)

 

 

 

 

 

 

Deduct:  Total stock-based employee compensation expense determined under fair value based method for all awards *

 

(445,550

)

(777,549

)

 

 

 

 

 

 

Pro-forma net loss **

 

$

(2,022,158

)

$

(1,226,431

)

Loss per share:

 

 

 

 

 

 

 

 

 

 

 

As reported, basic and diluted

 

$

(0.13

)

$

(0.06

)

 

 

 

 

 

 

Pro-forma, basic and diluted

 

$

(0.17

)

$

(0.11

)


*              All awards refers to awards granted, modified, or settled in fiscal periods beginning after December 15, 1994 - awards for which the fair value was required to be measured under FAS 123.

 

**           For purposes of pro-forma disclosures, the estimated fair value of the options is amortized over the options’ vesting period.  Pro-forma information regarding earnings and per share information is required by FAS 123, and has been determined as if the Company had accounted for its employee stock options under the fair value method of that Statement.  The fair value of these options was estimated at the date of grant using a Black-Scholes option pricing model for years subsequent to 2000.  Prior to 2001, the fair value of the options was valued using the minimum value method.

 

4.        Inventories

 

Inventories are stated at the lower of cost (first-in, first-out) or market.  The major classifications of inventories are as follows:

                                   

 

 

September 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

(Unaudited)

 

(Audited)

 

 

 

 

 

 

 

Raw materials

 

$

22,430

 

$

24,539

 

Finished goods

 

2,335,484

 

2,143,530

 

Finished goods held at distributors

 

1,147,940

 

1,734,955

 

 

 

 

 

 

 

 

 

$

3,505,854

 

$

 3,903,024

 

 

 

 

 

 

 

Less reserve for slow moving, excess and obsolete inventory

 

(1,753,954

)

(1,177,716

)

 

 

 

 

 

 

Net Inventory

 

$

1,751,900

 

$

2,725,308

 

 

5.        Property and Equipment

 

Property and equipment at September 30, 2005 and December 31, 2004 are comprised of the following:

 

 

 

September 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

(Unaudited)

 

(Audited)

 

 

 

 

 

 

 

Equipment

 

$

448,706

 

$

390,342

 

Software

 

35,634

 

35,634

 

Furniture and fixtures

 

36,472

 

31,210

 

Leasehold improvements

 

22,954

 

22,954

 

 

 

 

 

 

 

 

 

$

543,766

 

$

480,140

 

 

 

 

 

 

 

Less accumulated depreciation

 

(427,240

)

(376,951

)

 

 

 

 

 

 

 

 

$

116,526

 

$

103,189

 

 

Depreciation expense was $19,047 and $50,289 for the three and nine months ended September 30, 2005, respectively.

 

 

10



 

 

The estimated useful lives of the classes of physical assets were as follows:

 

 

 

Description

 

Depreciable Lives

 

 

 

 

 

 

 

Equipment

 

5 years

 

 

Software

 

3 years

 

 

Furniture and fixtures

 

7 years

 

 

Leasehold improvements

 

Term of lease

 

6.                          Accrued Expenses

                                   

 

 

September 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

(Unaudited)

 

(Audited)

 

 

 

 

 

 

 

Accrued audit and accounting expenses

 

$

176,800

 

$

165,000

 

Accrued legal expenses

 

423,000

 

37,000

 

Other accrued expenses

 

9,000

 

10,000

 

 

 

 

 

 

 

 

 

$

608,800

 

$

212,000

 

 

7.                          Deferred Contract Revenue

 

During September 2004, the Company entered into a funding agreement with United Binational Industrial Research and Development (“BIRD”) Foundation of Israel.  This agreement will provide funds to the Company for industrial research and development activities.  The agreement will provide up to a maximum of $560,000 of which the Company will may receive $280,000, and another partner in the agreement will receive the remainder.  The Company has recorded $101,379 in deferred contract revenue and for the nine months ended September 30, 2005 recorded $23,101 as an offset to research and development expenses.  There was no revenue recorded under this agreement for the three months ended September 30, 2005.

 

8.                          Stockholders’ Equity

 

Stock Options

 

During the three months ended September 30, 2005, no options to purchase shares of common stock under the 1997 Employee, Director and Consultant Stock Option Plan were approved by the Board of Directors.

 

 

9.        Related Party Transactions

 

The Company rents its facility from an entity controlled by a stockholder for $4,400 per month pursuant to a lease that expires on December 31, 2005.  See Liquidity - Note 1 - for additional related party transactions.

 

 

 

11



 

10.       License Agreement

 

On February 13, 2001, the Company signed an exclusive license agreement with ST Microelectronics NV (“ST”) of the Netherlands.  The agreement calls for ST to use certain intellectual property rights owned or controlled by the Company to commercialize and sell related products utilizing such technology.  In consideration for this license, ST paid to the Company a one-time license fee of $1.6 million in cash and a $400,000 credit for future design services completed in 2004.

 

The Company received royalties based on certain formulas, as defined in the agreement.  Royalties were earned based upon shipments by ST of commercialized products that incorporated technology licensed to ST by the Company.  Royalty income has been recognized during the period in which the royalties are earned.  Shipments have been reported to the Company using a “Royalty Schedule,” which is received within 30 days of quarter end.  Royalties are determined based upon either a percentage of selling price or a flat rate depending on the particular product.  This agreement has no expiration date; however, either party may cancel the agreement upon advance notice in certain circumstances as defined in the agreement.  Total royalties received under this Agreement were approximately $208,800 and $460,100 for the three and nine months ended September 30, 2005.   For the restated three and nine months ended September 30, 2004 total royalties received were approximately $446,000 and $890,400, respectively.

 

On May 3, 2005, the Company signed an amendment to the license agreement with ST, whereby; 1) the DDX technology license rights were changed from an exclusive license to a non-exclusive license, 2) the license royalty terms were modified and 3) terms related to Apogee interest transfers were modified. The effective date for terms 1 and 3 above was January 1, 2005 and for item 2 was January 1, 2004.

 

On October 5, 2005 the Company sold its stream of royalty payments, under the ST license agreement, as a part of the transactions with SigmaTel more fully set forth below in Note 13.

 

11.       Concentrations

 

During the three months ended September 30, 2005, the Company derived approximately 12% of its total revenue from one end user and 41% of total revenue as a result of sell through by two distributors.

 

During the three months ended September 30, 2005, the Company derived approximately 16% of its product revenue from one end user and 64% of product revenue as a result of sell through by three distributors.

 

During the nine months ended September 30, 2005, the Company derived approximately 25% of its total revenue from two end users and 43% of total revenue as a result of sell through by two distributors.

 

During the nine months ended September 30, 2005, the Company derived approximately 22% of its product revenue from 1 end user and 44% of product revenue as a result of sell through by 2 distributors.

 

During the restated three months ended September 30, 2004, the Company derived approximately 22% of its total revenue from one end user and 55% of total revenue as a result of sell through by two distributors.

 

During the restated three months ended September 30, 2004, the Company derived approximately 12% of its product revenue from one end user and 79% of product revenue as a result of sell through by two distributors.

 

During the restated nine months ended September 30, 2004, the Company derived approximately 36% of its total revenue from two end users and 34% of total revenue as a result of sell through by two distributors.

 

 

12



 

 

During the restated nine months ended September 30, 2004, the Company derived approximately 22% of its product revenue from one end user and 48% of product revenue as a result of sell through by two distributors.

 

During the three months ended September 30, 2005, the Company derived approximately 70% and 14% of its total revenue from end users or distributors located in Asia and Europe, respectively.

 

During the three months ended September 30, 2005, the Company derived approximately 91% of its product revenue from end users or distributors located in Asia.

 

During the nine months ended September 30, 2005, the Company derived approximately 74% and 12% of its total revenue from end users or distributors located in Asia and Europe, respectively.

 

During the nine months ended September 30, 2005, the Company derived approximately 88% of its product revenue from end users or distributors located in Asia.

 

During the restated three months ended September 30, 2004, the Company derived approximately 65% and 22% of its total revenue from end users or distributors located in Asia and Europe, respectively.

 

During the restated three months ended September 30, 2004, the Company derived approximately 93% of its product revenue from end users or distributors located in Asia.

 

During the restated nine months ended September 30, 2004, the Company derived approximately 69% and 20% of its total revenue from end users or distributors located in Asia and Europe, respectively.

 

During the restated nine months ended September 30, 2004, the Company derived approximately 94% of its product revenue from end users or distributors located in Asia.

 

Four of the Company’s customers accounted for approximately 73% of the total accounts receivable balance at September 30, 2005.

 

Three of the Company’s customers accounted for approximately 71% of the total accounts receivable balance at restated September 30, 2004.

 

Three of the Company’s major vendors accounted for approximately 98% of total purchases for the nine months ended September 30, 2005.

 

One of the Company’s major vendors accounted for approximately 94% of total purchases for the nine months ended September 30, 2004.

 

The Company maintains accounts with financial institutions.  Balances usually exceed the maximum coverage ($100,000) provided by the Federal Deposit Insurance Corporation on insured depositor accounts.

 

 

13



 

 

12.          Supplementary Financial Information (unaudited)

 

Restatement of Previously Reported Quarterly Financial Information

 

As a result of management’s decision to change the accounting method for recognizing product revenue from distributors to a sell through or point of sale (POS) method and the internal investigation concerning the circumstances surrounding the appropriate accounting for product revenue, the Audit Committee of the Board of Directors has determined that the Company restate certain financial information previously reported in the Company’s Form 10-QSB for the quarters ended March 31, 2004, June 30, 2004 and September 30, 2004.

 

The following table provides a reconciliation of amounts previously reported in the Company’s Form 10-QSB for the quarter ended September 30, 2004 with amounts previously adjusted for the restatement as a result of the change in accounting policy and as a result of the Audit Committee’s investigation.  In reviewing the restated Consolidated Statement of Operations, it should be taken into consideration that the restated financial information reflects unaudited adjustments.

 

APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

 RESTATED CONSOLIDATED BALANCE SHEET (unaudited)

(in thousands)

 

 

 

September 30, 2004

 

 

 

Previously

 

Restatement

 

Restated

 

 

 

Reported(1)

 

Adjustment

 

Total

 

ASSETS

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

2,511

 

$

 

$

2,511

 

Accounts receivable, net(2)

 

3,297

 

(2,247

)

1,050

 

Inventories, net(3)

 

1,845

 

1,404

 

3,249

 

Prepaid expenses and other current assets

 

221

 

 

221

 

Deferred tax asset(4)

 

195

 

(195

)

 

Total current assets

 

8,069

 

(1,038

)

7,031

 

Property and equipment, net

 

114

 

0

 

114

 

Other assets

 

 

 

 

 

 

 

Patents, net

 

109

 

 

109

 

Other intangible assets(5)

 

173

 

(59

)

114

 

 

 

$

8,465

 

$

(1,097

)

$

7,368

 

Current liabilities

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

1,606

 

$

 

$

1,606

 

Deferred distributor revenue(6)

 

 

1,354

 

1,354

 

Deferred contract revenue

 

96

 

 

96

 

Deferred warranty

 

 

 

 

Total current liabilities

 

1,702

 

1,354

 

3,056

 

Stockholders’ equity

 

 

 

 

 

 

 

Common stock

 

118

 

 

118

 

Additional paid-in capital

 

18,074

 

 

18,074

 

Accumulated deficit

 

(11,429

)

(2,451

)

(13,880

)

Total stockholders’ equity

 

6,763

 

(2,451

)

4,312

 

 

 

$

8,465

 

$

(1,097

)

$

7,368

 

 

 

14



 

Restatement of Previously Reported Quarterly Financial Information

 

(1)   As previously reported in the Company’s Quarterly Reports on Form 10-QSB.

 

(2)   Accounts Receivable:  Restatement for September 30, 2004 consists of $2,247,000 reduction associated with the deferred revenue utilizing the sell through method.

 

(3)   Inventory:  Restatement for September 30, 2004 represents an increase of $2,174,000 for finished goods inventory held at distributors.  This amount was adjusted by $770,000 of reserves against inventory held at distributors and in-house.

 

(4)   Deferred Tax Asset: The $195,000 originally recorded for the fiscal year ended December 31, 2003 was deemed no longer applicable based upon restatement of the Fiscal Year ended December 31, 2003.

 

(5)   Other Intangible Assets: The $59,000 adjustment reflects with expensing of various items previously being amortized.

 

(6)  Deferred Distributor Revenue:  The restatement reflects the change in recognition of reporting distributor revenue to a sell through or point of sale method of accounting revenue.  This number is based on POS reports received by the Company’s distributors.

 

 

 

 

15


 


APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

RESTATED CONSOLIDATED STATEMENT OF OPERATIONS (unaudited)

(in thousands, except per share data)

 

 

 

 

 

Three Months Ended September 30, 2004

 

 

 

Previously

 

Restatement

 

Restated

 

 

 

Reported(1)

 

Adjustment

 

Total

 

Revenues

 

 

 

 

 

 

 

Product sales(2)

 

$

1,133

 

$

257

 

$

1,390

 

Royalties(3)

 

790

 

(344

)

446

 

Consulting

 

161

 

 

161

 

 

 

2,084

 

(87

)

1,997

 

Costs and expenses

 

 

 

 

 

 

 

Product sales(4)

 

760

 

394

 

1,154

 

Research and development

 

664

 

-.-

 

664

 

Selling, general and administrative(5)

 

988

 

(355

)

633

 

 

 

2,412

 

39

 

2,451

 

Operating loss

 

(328

)

(126

)

(454

)

Other (expense) income

 

 

 

 

 

 

 

Interest expense

 

 

 

 

Interest income

 

5

 

 

5

 

 

 

5

 

 

5

 

Net Income (Loss) before Taxes

 

(323

)

(126

)

(449

)

Income Tax Benefit

 

 

 

 

Net (Loss) Income

 

(323

)

(126

)

(449

)

Accumulated deficit - beginning

 

(11,107

)

(2,324

)

(13,431

)

Accumulated deficit - ending

 

$

(11,429

)

$

(2,450

)

$

(13,880

)

Basic and diluted loss per common share

 

$

(0.03

)

$

(0.03

)

$

(0.06

)

Weighted average common shares outstanding - basic and diluted

 

11,566

 

 

 

 

 

 

 

16



 

 

 

Restatement of Previously Reported Quarterly Financial Information

 

(1)   As previously reported in the Company’s Quarterly Reports on Form 10-QSB.

 

(2)    Product Sales:  The restated number reflect the change in recognition of reporting of distributor revenue to a sell through or point of sale method of accounting and is based on reports from the Company’s distributors.  This change translated into a net increase of $257,000 for the three months ended September 30, 2004.

 

(3)   Royalty Revenue:  The restated royalty revenue reflects the net effect of the discount given to STMicroelectronics for specific customers of $344,000 for the three months ended September 30, 2004.   These discounts were originally recorded in SG & A as a royalty expense.

 

 (4)    Cost of Product Sales:  The restated numbers reflect the change in the cost of goods sold based on the change in recognition of reporting of distributor revenue to a sell through or point of sale method of accounting.

 

(5)     Selling, General and Administrative:  The $355,000 reduction in SG&A was the result of the restatement of the royalty expense associated with discounts given to STMicroelectronics for specific customer.  These discounts have been restated against royalty revenue for the three months ended September 30, 2004.  In addition there was a reduction of $11,000 as a result of the recording of these commissions in a prior quarter.

 

 

17



 

 

Restatement of Previously Reported Quarterly Financial Information

 

APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

RESTATED CONSOLIDATED STATEMENT OF OPERATIONS (unaudited)

(in thousands, except per share data)

 

 

 

 

Nine Months Ended September 30, 2004

 

 

 

Previously

 

Restatement

 

Restated

 

 

 

Reported(1)

 

Adjustment

 

Total

 

Revenues

 

 

 

 

 

 

 

Product sales(2)

 

$

3,866

 

$

63

 

$

3,928

 

Royalties(3)

 

1,601

 

(711

)

890

 

Consulting

 

615

 

50

 

665

 

 

 

6,082

 

(598

)

5,483

 

Costs and expenses

 

 

 

 

 

 

 

Product sales(4)

 

2,500

 

742

 

3,240

 

Research and development

 

1,981

 

 

1,982

 

Selling, general and administrative(5)

 

2,628

 

(722

)

1,906

 

 

 

7,109

 

20

 

7,128

 

Operating loss

 

(1,027

)

(618

)

(1,645

)

Other (expense) income

 

 

 

 

 

 

 

Interest expense

 

 

 

 

Interest income

 

16

 

 

16

 

 

 

16

 

 

16

 

Net Income (Loss) before Taxes

 

(1,011

)

(618

)

(1,629

)

Income Tax Benefit

 

 

 

 

Net (Loss) Income

 

(1,011

)

(618

)

(1,629

)

Accumulated deficit - beginning

 

(10,418

)

(3,462

)

(13,880

)

Accumulated deficit - ending

 

$

(11,429

)

$

(4,080

)

$

(15,509

)

Basic and diluted loss per common sha

 

$

(0.09

)

$

(0.05

)

$

(0.14

)

Weighted average common shares outstanding - basic and diluted

 

11,429

 

 

 

 

 

 

 

18



 

Restatement of Previously Reported Quarterly Financial Information

 

(1)    As previously reported in the Company’s Quarterly Reports on Form 10-QSB.

 

(2)    Product Sales:  The restated number reflect the change in recognition of reporting of distributor revenue to a sell through or point of sale method of accounting and is based on reports from the Company’s distributors.  This change translated into a net increase of $63,000 for the nine months ended September 30, 2004.

 

(3)   Royalty Revenue:  The restated royalty revenue reflects the net effect of the discount given to ST for specific customers of $711,000 for the nine months ended September 30, 2004.   These discounts were originally recorded in SG & A as a royalty expense.

 

 (4)    Cost of Product Sales:  The restated numbers reflect the change in the cost of goods sold based on the change in recognition of reporting of distributor revenue to a sell through or point of sale method of accounting.

 

(5)     Selling, General and Administrative:  The $722,000 reduction in SG& A was the result of the restatement of the royalty expense associated with discounts given to STMicroelectronics for specific customer.  These discounts have been restated against royalty revenue for the nine months ended September 30, 2004.  In addition there was a reduction of $11,000 as a result of the recording of commissions in a prior quarter.

 

13.          Subsequent Events

 

On October 5, 2005, Apogee Technology, Inc. (the “Company”) completed a transaction with SigmaTel, Inc. (“SigmaTel”), whereby certain assets of the audio division were sold, including the Direct Digital Amplifier (DDX®) technology and the associated royalties from its license agreement with ST, to SigmaTel for approximately $9.4 million plus a one-year earn-out of potentially up to $4.5 million (the “Transaction”). No assurance can be given that this earn-out will be realized.  In addition, the Company’s engineering and marketing staff related to the audio division were offered positions at SigmaTel as a part of the Transaction.

 

The Company used proceeds from the Transaction to repay approximately $2.1 million owed to Laurus Master Fund, Ltd., pursuant to the Company’s Secured Convertible Note and the related Securities Purchase Agreement dated as of August 9, 2005 and to pay certain expenses related to the Transaction.  The Company intends to use the proceeds to design, develop and market its emerging line of MEMS-based products.

 

Although the Company retained substantially all of its audio division related agreements (with the exception of the royalty rights from the license agreement with ST) and its DDX inventory, the Company intends to discontinue the operations of its audio division upon completing the sale of these remaining assets.

 

On October 20, 2005 proceeds from the SigmaTel transaction were used to repay the $250,000 loan from David Spiegel, a shareholder and the $250,000 loan from Herbert Stein, Chief Executive Officer, President and Chairman of the Board as well as all accrued interest.

 

The Company and certain of the Principal Stockholders also entered into an additional Indemnification Agreement.  The Company is authorized to indemnify the Principal Stockholders in the event any one or more of them has to satisfy any obligations thereunder.

 

The following Table presents the pro-forma effect of the DDX technology sale and subsequent payment on the Notes as of September 30, 2005.

 

19



 

APOGEE TECHNOLOGY, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS (unaudited) (in Thousands)

 

 

 

As Reported
September 30,
2005

 

Effect of DDX
Sale and Note
Repayment

 

Pro Forma
September 30,
2005

 

ASSETS

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

812

 

$

5,519

(1)(2)

$

6,331

 

Accounts receivable, net of allowance

 

465

 

 

465

 

Inventories, net

 

1,952

 

 

1,952

 

Deferred costs other

 

368

 

(368)

(3)

 

Deferred note financing costs

 

306

 

(306)

(4)

 

Prepaid expenses and other current assets

 

62

 

 

62

 

Total current assets

 

3,965

 

4,845

 

8,810

 

Property and equipment, net of accumulated depreciation of $427

 

117

 

(100)

(3)

17

 

Other assets

 

 

 

 

 

 

 

Patent, net of accumulated amortization of $147

 

266

 

(170)

(3)

96

 

Escrow

 

 

320

(1)(3)

320

 

 

 

$

4,348

 

$

4,895

 

$

9,243

 

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

1,706

 

$

(676)

(1)(2)

$

1,030

 

Deferred distributor revenue

 

1,724

 

-

 

1,724

 

Note payable other

 

2,000

 

(2,000)

(2)

 

Officer and shareholder loans

 

500

 

(500)

(2)

 

Advances

 

205

 

(205)

(1)

 

Deferred contract revenue

 

73

 

 

73

 

Total current liabilities

 

6,208

 

(3,381

)

2,827

 

Commitments and Contingencies

 

 

 

 

Stockholders' equity (deficiency)

 

 

 

 

 

 

 

Common stock, $.01 par value;

 

 

 

 

 

 

 

20,000,000 shares authorized, 11,838,332 issued and outstanding at September 30, 2005 and December 31, 2004

 

118

 

 

118

 

Additional paid-in capital

 

18,074

 

 

18,074

 

Accumulated deficit

 

(20,052

)

8,276

(3)(4)

(11,776

)

Total stockholders' equity (deficiency)

 

(1,861

)

8,276

 

6,416

 

 

 

$

4,348

 

$

4,895

 

$

9,243

 

 

 

20



 

 

Notes to above Balance Sheet

 

 

 

 

(1) The DDX sale proceeds are as follows:

 

Gross proceeds

 

$

9,420

 

 

Less payoff of trade accounts payable

 

(661)

 

 

Less payoff advance

 

(205)

 

 

Less escrow

 

(420)

 

 

Cash from DDX sale

 

$

8,134

 

 

 

 

 

(2) Proceeds used for note repayment:

 

Cash from DDX sale

 

$

8,134

 

 

Less Laurus note

 

(2,000)

 

 

Less premium on Laurus note and interest

 

(115)

 

 

Less shareholder notes

 

(500)

 

 

Net cash per above

 

$

5,519

 

 

 

 

 

(3) Gain on DDX sale:

 

Gross proceeds

 

$

9,420

 

 

Less assets sold

 

(270)

 

 

Less escrow reserve

 

(100)

 

 

Less deferred deal costs

 

(368)

 

 

 

 

 

 

 

Net gain

 

$

8,682

 

 

 

 

 

(4) Loss on note payment:

 

Less premium on Laurus note

 

$

(100)

 

 

Less deferred financing costs

 

(306)

 

 

Loss on note payment

 

$

(406)

 

 

Net gain per above

 

$

8,276

 

 

Since the Company has generated substantial net operating loss carry forwards, no tax effect is expected as a result of these transactions.

 

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

GENERAL

 

The following Management’s Discussion and Analysis of the Company’s Financial Condition and Results of Operations for the three-and nine-month periods ended September 30, 2005 and restated September 30, 2004 should be read in conjunction with the Company’s Financial Statements and related Notes included elsewhere in this Quarterly Report on Form 10-QSB. This discussion contains, in addition to historical statements, forward-looking statements that involve risks and uncertainties. The Company’s actual results could differ significantly from the results discussed in the forward-looking statements. Factors that could cause or contribute to such differences include the factors discussed in the section titled “Certain Risk Factors That May Affect Future Results of Operations And Our Common Stock Price” as well as other factors described in the Company’s Annual Report on Form 10-KSB for the year ended December 31, 2004. The Company does not intend to update any such forward-looking statements.

 

OVERVIEW

 

The Company has traditionally designed, developed, and marketed silicon based products incorporating proprietary technologies.  The Company is currently in the process of evolving from an audio focused enterprise to a Micro-Electromechanical Solutions (“MEMS”) provider.  The Company is developing new System-on-Chip (“SOC”) products using its analog and digital circuit designs and MEMS technology for the consumer, automotive, communications and medical markets. Historically, under a licensing agreement with STMicroelectronics NV (“ST”), the Company developed intellectual property for use in royalty bearing products produced by ST. On October 5, 2005 the Company sold its audio business to SigmaTel, Inc., through the sale of assets associated with Direct Digital Amplification (DDX®) technology, as detailed in Note 13 — Subsequent Events, and as a result will discontinue its audio division after completing the sale of its remaining audio division assets.   Previous to the asset sale, the Company’s efforts had been focused as designing, developing and marketing patented all-digital, high efficiency DDX technology Integrated Circuits (“ICs”) which are used in a range of audio applications including:  home theater systems, powered speakers, car audio, commercial audio and PC multi-

 

 

21



 

 

media.  The Company has traditionally generated revenue from the sale of IC’s, IC related products, consulting work for third parties as well as royalties and license fees earned under the agreement with ST and other third parties.  The Company has marketed its products using a worldwide network of direct sales staff, independent sales representatives and distributors.  A primary goal in connection with the transition to the MEMS business is to use and leverage the experience in technology, development, and its international sales experience developed from the years in the audio business.   Now that the Company has chosen to evolve into a MEMS based solutions provider and due to a non-compete agreement associated with the October 5, 2005 sale of assets, the Company has chosen to exit the audio space entirely; and by the terms of a non-compete with SigmaTel, it cannot compete in the Class D audio/amplifier business for two years. The Company incurred a net loss of approximately $1.6 million and $4.6 million for the three and nine months ended September 30, 2005, as compared to a loss of approximately $449,000 and $1.6 million for the restated three and nine months ended September 30, 2004.  As of September 30, 2005, the Company had an accumulated deficit of approximately $20.2 million, as compared to a deficit of approximately $15.6 million at December 31, 2004.  The Company’s net losses and accumulated deficit (since 1995) result primarily from research costs associated with the Company’s efforts to develop and market its DDX technology.

 

As of September 30, 2005, the Company had 36 employees.  As a result of the audio business sale, the Company the Company has 11 employees.

 

During the three-month period ended September 30, 2005, the Company derived approximately 53% of its total revenue and 80% of its product revenue from three and four customers, respectively all of which was attributable to the audio division.  The Company has utilized a network of sales representatives and distributors, as well as sales offices in China, Hong Kong, Japan and Taiwan, to support the Company’s worldwide sales and marketing activities.  The Company is currently closing down its locations in China and Taiwan.

 

 

SELECTED CONSOLIDATED FINANCIAL DATA

 

 

The following selected financial data for the three- and nine-month periods ended September 30, 2005 and restated September 30, 2004 have been derived from the Company’s unaudited financial statements.  Any trends reflected by the following table may not be indicative of future results.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three-Month Period
Ended
 September 30,

 

For the Nine-Month Period
Ended
 September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

 

 

(Restated)

 

 

 

(Restated)

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

Revenue

 

$

1,520,186

 

$

1,995,817

 

$

3,949,566

 

$

5,482,983

 

Costs and expenses

 

(3,066,056

)

(2,450,063

)

(8,535,375

)

(7,128,163

)

Other Income (expenses)

 

(30,738

)

5,365

 

(28,065

)

16,249

 

Net Loss

 

$

(1,576,608

)

$

(448,881

)

$

(4,613,874

)

$

(1,628,931

)

 

 

 

 

 

 

 

 

 

 

Shares Outstanding

 

11,838,332

 

11,796,332

 

11,838,332

 

11,796,332

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet Data:

 

 

 

 

 

 

 

 

 

Total Assets

 

$

4,148,235

 

$

7,367,886

 

$

4,348,235

 

$

7,367,886

 

Stockholders’ equity (deficiency)

 

$

(2,059,214

)

$

4,311,104

 

$

(2,059,214

)

$

4,311,104

 

Loss per share (basic and diluted)

 

$

(0.13

)

$

(0.06

)

$

(0.39

)

$

(0.14

)

 

 

22



 

RESULTS OF OPERATIONS OF THE COMPANY

 

 

The following table sets forth, for the periods indicated, the percentage of total revenue represented by certain revenue and expense items.  The table and the discussion below should be read in conjunction with the consolidated financial statements and notes thereto that appear elsewhere in this report.

 

 

 

 

For the Three Months Ended
September 30,

 

For the Nine Months Ended
September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

 

 

(Restated)

 

 

 

(Restated)

 

 

 

 

 

 

 

 

 

 

 

Product Sales

 

76.16

%

69.55

%

84.22

%

71.62

%

Royalties

 

13.97

 

22.37

 

11.98

 

16.24

 

Consulting/Licensing

 

9.87

 

8.08

 

3.80

 

12.14

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

(73.81

)

(57.79

)

(75.33

)

(59.09

)

Research and Development

 

(51.66

)

(33.25

)

(58.45

)

(36.15

)

Sales, General and Administrative

 

(76.21

)

(31.70

)

(82.33

)

(34.76

)

 

 

 

 

 

 

 

 

 

 

Operating Loss

 

(101.68

)%

(22.74

)%

(116.11

)%

(30.00

)%

Other Income (Expense)

 

(2.02

)

0.25

 

(0.71

)

0.31

 

Net Loss

 

(103.70

)%

(22.49

)%

(116.82

)%

(29.71

)%

 

Revenue

 

The Company has traditionally derived its revenue from three sources: (1) product sales, which consist of merchandise sales made either directly to original equipment manufacturers or sell through (point of sale) by distributors, all shipments are fulfilled from the Company’s warehouses in Hong Kong and/or Norwood, Massachusetts and revenue is reported net of returns; (2) royalty revenue, which consists of royalties paid by STMicroelectronics under the terms of the licensing agreement signed in February 2001 and (3) consulting income related to the development of custom ICs for STMicroelectronics and other third parties who are developing DDX and non-DDX based solutions.     See Note 2 of the financial statements — Revenue Recognition.

 

Total revenue declined by approximately $500,000 or 24% to $1.5 million for the three months ended September 30, 2005 from the restated three months ended September 30, 2004 of approximately $2.0 million.    Total revenue decreased by approximately 28% or $1.5 million to approximately $4.0 million for the nine months ended September 30, 2005 from approximately $5.5 million for the restated nine months ended September 30, 2004.  This decrease in revenue was due to reduced sales to the Company’s largest customers.

 

Revenue from the sale of the Company’s products, consisting of IC’s, as well as IC evaluation and reference boards, decreased by approximately17% or $200,000 to approximately $1.2 million for the three months ended September 30, 2005 from approximately $1.4 million for the restated three months ended September 30, 2004.  Product revenue also decreased by approximately 15% or $600,000 to approximately $3.3 million for the nine months ended September 30, 2005 as compared to $3.9 million for the restated nine months ended September 30, 3004. This decrease in product sales was related to weakness in demand from its key customers.

 

Revenue from non-product related items accounted for approximately 24% and 16% of total revenue for the three and nine months ended September 30, 2005, respectively, compared to revenue from non-product related items of approximately 30% and 28% of total revenue for the restated nine months ended September 30, 2004.  During the three and nine months ended September 30, 2005, the Company recorded royalties of approximately $212,000 and $473,000, compared to royalties of approximately $446,000 and $890,000 for the restated three and nine months ended September 30, 2004, representing a decrease of approximately 52% and 47% for the respective periods. The decrease in royalties is primarily due to the reduction in average selling prices of the products sold by STMicroelectronics and reduced royalty rates on certain products.  During the three- and nine-month periods ended September 30, 2005, the Company recorded $150,000 of consulting revenue as compared to approximately $161,000 and $665,800 of consulting revenue recorded for the restated three- and nine-month periods ended September 30, 2004.

 

Total revenue for the three and nine months ended September 30, 2005 and restated 2004 consisted of:

 

 

23



 

 

 

 

 

 

 

 

 

 

 

 

For the Three-Month Period
Ended September 30, (Unaudited)

 

For the Nine-Month Period Ended
September 30, (Unaudited)

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

 

 

(Restated)

 

 

 

(Restated)

 

Product Revenue

 

$

1,157,789

 

$

1,388,132

 

$

3,326,238

 

$

3,926,841

 

Royalties

 

212,397

 

446,415

 

473,328

 

890,388

 

Consulting

 

150,000

 

161,270

 

150,000

 

665,754

 

 

 

 

 

 

 

 

 

 

 

Total:

 

$

1,520,186

 

$

1,995,817

 

$

3,949,566

 

$

5,482,983

 

 

Revenue from DDX products is expected to diminish over the next few quarters as DDX inventory is sold and deferred revenue is recognized through the POS reporting by distributors.  In addition, licensing revenue from the ST Licensing Agreement has been assigned in conjunction the sale of certain DDX assets.

 

It is anticipated that nominal revenue from MEMS’ related products will be generated by the end of 2005.

 

Cost of Revenue

 

Cost of revenue decreased as a result of reduced product revenue to approximately $922,000 and $2.8 million for the three and nine months ended September 30, 2005, respectively, compared to approximately $1.2 million and $3.2 million for the restated three and nine months ended September 30, 2004.  Cost of revenue primarily consists of purchasing finished semiconductor chips and costs associated with assembly, testing and shipping of those products as well as customs and storage fees associated with warehousing a large portion of the Company’s semiconductor products in Asia.  In addition, the Company has established reserves for slow moving, excess and obsolete inventories held at Apogee and at its distributors.  These provisions are reported as part of the Cost of Revenue.  Provisions for the three and nine months ended September 30, 2005 were approximately $255,000 and $576,000 compared to approximately $278,000 and $420,000 for the restated three and nine months ended September 30, 2004.  For the three and nine months ended September 30, 2005, the Company had gross margins before inventory reserve provisions of approximately 25% and 28%, respectively, compared to 37% and 28% in the same periods in 2004, as restated. This was due to price erosion on the sale of existing products, not offset by sales of higher margin newer products. Although the Company increased its reserve, no inventory write-off was recorded for either the three or nine months ended September 30, 2005 or the restated three and nine months ended September 30, 2004.  The Company is monitoring its inventory and as of September 30, 2005, the Company believes the reserves in place are adequate but will continue to re-evaluate on a quarterly basis or more frequently if market conditions warrant.

 

Research and Development (“R&D”) Expenses

 

Research and development expenses consist primarily of salaries and related expenses in the design, development and technical support of the Company’s products as well as direct support to current and potential customers.  Research and development expenses increased to approximately $785,000 and $2.3 million for the three months and nine months ended September 30, 2005, compared to approximately $664,000 and $2.0 million for the restated three and nine months ended September 30, 2004. This increase of approximately $121,000 or 18% and $326,000 or 16%, respectively, was primarily due to the acquisition of the MEMS Division and the related increased human resource costs of this new division partially offset by a reduction in vendor expenses.  For the three and nine months ended September 30, 2005 vendor expenses accounted for approximately $22,000 and $144,000 of total research and development costs, down from $61,000 and $294,000, respectively, for the restated three and nine month periods ended September 30, 2004.  Costs related to human resources for R&D were approximately $560,000 and $1.7 million for the three months and nine months ended September 30, 2005, compared to approximately $533,000 and $1.5 million for the restated three and nine months ended September 30, 2005.  This increase of $28,000 or 5% and $174,000 or 12% for the respective periods was a result of additional staffing for the new MEMS Division partially offset by a reduction in the human resource costs related to the audio Division.  During the nine months ended September 30, 2005, the Company introduced two IC products and one MEMS product.  The Company continues to invest in the development of its MEMS products. Due to the technical nature of the Company’s products, engineering and design support are critical parts of the Company’s strategy during both the development of its products and the support to its customers from product design to final production.  Management anticipates that it will continue to commit resources to research and development of MEMS related activities, but with the divestiture of the Company’s DDX Division in October 2005, R&D costs are expected to be reduced at least for the short term.  See Subsequent Events — Footnote 13 to the financial statements.

 

 

24



 

Selling, General and Administrative (“SG&A”) Expenses

 

Selling expenses consist primarily of salaries and related expenses for personnel engaged in the marketing and sales of the Company’s products, as well as costs related to trade shows, product literature, travel and other promotional support costs. In addition, selling expenses include costs of its Asian sales offices and support staff.  General and administrative costs consist primarily of executive and administrative salaries, professional fees and other associated corporate expenses. The increase in SG&A was attributable principally to professional fees as well as increased support for the Company’s Asian offices and increased human resource costs.  SG&A expenses were approximately $1.2 million and $3.3 million for the three and nine months ended September 30, 2005, compared to approximately $632,000 and $1.9 million for the restated three and nine months ended September 30, 2004, an increase of approximately $526,000 or 83% and $1.3 million or 71%, respectivelyProfessional expenses increased approximately $425,000 or 364% and $1.1 million or 351% to approximately $542,000 and $1.4 million for the three and nine months ended September 30, 2005 compared to approximately $117,000 and $300,000 for the restated three and nine months ended September 30, 2004.  Of this increase for the three months and nine months ended September 30, 2005, approximately $60,000 and $500,000, respective, was due to the legal expense associated with the Audit Committee’s investigation and subsequent restatement of the Company’s financial statements.  In addition, approximately $204,000 and $248,000 for the three and nine months ended September 30, 2005 was additional accounting expense related to the Audit Committees investigation and the Company’s restatement of the its financial statements.  The Company expects that administrative expenses will decrease now that it has become current with its SEC Filings.  Investor Relations, Public Relations, Recruiting and Director Fees accounted for a majority of the remaining increase in professional fees. Human resource costs increased approximately $81,000 and $126,000 to approximately $352,000 and $1.0 million during the three months and nine months ended September 30, 2005 compared to approximately $271,000 and $904,000 during the same periods in 2004, as restated, an increase of 30% and 14%, respectively.  This increase was primarily due to higher compensation, as well as, an increase in domestic staffing. Travel expense increased by approximately $8,000 or 15% and $62,000 or 39% to approximately $59,000 and $221,000 for the three and nine months ended September 30, 2005 compared to approximately $52,000 and $159,000 for the restated three and nine months ended September 30, 2004.  In addition, the Company increased the allowance for doubtful accounts by $15,000 and $40,000 for the three and nine months ended September 30, 2005 compared to $5,000 and $10,000 increase in the allowance for the restated three and nine months ended September 30, 2004.  Operating expenses are expected to be reduced over the next few quarters due to a reduction of staffing and other deductions as a result of the sale of certain DDX assets.  This trend is expected to continue until such time as staffing and other spending increases in conjunction with building the MEMS business.

 

Interest Income (Expense)

 

Interest income includes income from the Company’s cash and cash equivalents and from investments and expenses related to its financing activities.  During the three and nine months ended September 30, 2005, the Company generated interest income of approximately $4,800 and $10,900 compared to interest income of approximately $5,400 and $16,300 during the same periods in 2004.  As a result of the loans by Laurus Master Fund, Ltd. in August 2005 and loans by Mr. Herbert M. Stein and Mr. David Spiegel in May 2005, the Company incurred interest expense of approximately $17,400 and $20,900 for the three and nine months ended September 30, 2005.  This decrease in interest income for the three and nine months ended September 30, 2005 was primarily due to reduced interest on reduced cash as of September 30, 2005.

 

Financing costs of $324,000 were incurred as a result of the Laurus Master Fund, Ltd. Loan and recorded as deferred financing costs as of September 30, 2005.  During the three and nine months ended September 30, 2005, the Company recorded $18,000 of financing costs. These costs were paid in full upon completion of the SigmaTel transaction. See Subsequent Events — Note 13 to the financial statements.

 

Net Loss

 

The Company’s net loss for the three months ended September 30, 2005 was approximately $1.4 million or $0.12 per basic and diluted common share, compared to a net loss of approximately $449,000 or $0.06 per basic and diluted common share for the restated three months ended September 30, 2004.  For the nine months ended September 30, 2005 the Company reported a loss of approximately $4.4 million or $0.37 per basic and diluted common share, compared to a net loss of approximately $1.6 million or $0.14 per basic and diluted common share for the restated nine months ended September 30, 2004.

 

LIQUIDITY AND CAPITAL RESOURCES

 

The Company’s principal source of liquidity at September 30, 2005 consisted of approximately $812,000 in cash and short-term investments and $2.5 million of available short term financing.  See Liquidity Section of Basis of Presentation — Note 1 to the financial statements.  This compares to approximately $1.9 million in cash and cash equivalents at December 31, 2004.  This decrease in cash was due to increased working capital requirements.

 

Net cash used in operations during the nine-month period ended September 30, 2005 increased to approximately $3.4 million compared to approximately $1.7 million in the restated nine-month period ended September 30, 2004.  The increase was mainly due to an increase in net loss and increases in allowances for doubtful accounts, slow moving, excess and obsolete inventory and accounts receivable reserves.  As of September 30, 2005, inventory, net of reserves, was approximately $2.0 million compared to inventory of approximately $3.2 million as of September 30, 2004.  Net accounts receivable was approximately $465,000 at September 30, 2005, down from approximately $1.0 million at September 30, 2004.  As of September 30, 2005, four major customers accounted for

 

 

25



 

 

approximately 73% of the total accounts receivable balance.  The Company increased its reserve against bad debts to $145,000 as of September 30, 2005 from $105,000 as of December 31, 2004.  The Company believes this reserve is sufficient at this time.

 

Net cash used in investing activities for the nine months ended September 30, 2005 was approximately $138,000, compared to approximately $195,000 for the restated nine months ended September 30, 2004.

 

Net cash provided by financing activities for the nine months ended September 30, 2005 was approximately $2.5 million, compared to $1.9 million provided by financing activities for the nine months ended September 30, 2004.  During the nine-month period ended September 30, 2005, the Company received the proceeds from unsecured interest bearing loans in the amounts of $250,000 from David Spiegel, a shareholder and $250,000 from Herbert Stein, Chief Executive Officer, President and Chairman of the Board. These loans were payable upon demand and were not subject to any premium or penalty for prepayment. The loan interest rate is 6% per annum, payable monthly in arrears on the outstanding balance.   On August 11, 2005, the Company entered into agreements with Laurus Master Fund, Ltd., whereby the Company received $2.0 million in gross proceeds (with net proceeds of approximately $1.8 million) through the sale of a 120 day secured term note. In accordance with the terms of the note, the note was payable by the Company in cash during the first 120 days following the issuance of the note, and after the 120 day period it was payable in the amount of $62,500 per month in cash or convertible into the common stock, $0.01 par value per share, of the Company at a fixed conversion price of $1.05 per share. In connection with the financing, the Company paid certain costs and expenses of Laurus and has issued an immediately exercisable warrant with terms restricting exercise. The Laurus warrant provides for the purchase of 85,000 shares of common stock at a price of $1.22 per share. The warrant expires seven years after issuance. A finder for the transaction received a fee of 5% of the gross proceeds of the offering, together with a seven year warrant to purchase an aggregate of 8,500 shares of common stock immediately exercisable at a price of $1.22 per share. This offering was conducted as a private placement pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. With respect to the transaction with Laurus, the Company has entered into an agreement to register the common stock underlying the warrants and the common stock that may be received upon any conversion of the secured term note.  On October 5, 2005 proceeds from the SigmaTel transaction were used to repay the approximately $2.1 million owed to Laurus Master Fund, Ltd. as well as payment of certain expenses related to the transaction.

 

On August 24, 2004 the Company completed a private placement to accredited third party investors under Section 4(2) of the Securities Act and Regulation D, Rule 506, promulgated thereunder.  In connection with the private placement, the Company issued 374,242 shares at a price of $4.75 per share.  The Company received net proceeds of $1,648,177 from the saleDuring the three-month period ended September 30, 2004, the Company received $58,820 in cash from the exercise of options by one former employee and one former director.

 

The Company believes that cash flow from operations as well as the funds from the audio division sale — See Subsequent event — Note 13 to the financial statements, as well as, amounts that may be raised from time to time in private offerings of its common stock as well as the amounts received in debt financings will be sufficient to support operations and fund capital equipment requirements at least through 2006.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

The preparation of the consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses.  On an on-going basis, the Company evaluates its estimates, including those related to uncollectible accounts receivable, inventories, intangibles and other long-lived assets.  The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.  The Company maintains allowances for uncollectible accounts receivable for estimated losses resulting from the inability of its customers to make required payments.  If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company maintains allowances for estimated slow moving, excess or obsolete inventories including future non-cancelable purchase commitments based on the Company’s review of inventory levels, projected future sales and comparison of actual manufacturing costs to standard costs.  If actual market conditions are less favorable than those projected by management, additional allowances may be required. Property, plant and equipment, patents, trademarks and other intangible assets are amortized over their estimated useful lives.  Useful lives are based on management’s estimates over the period that such assets will generate revenue. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Future adverse changes in market conditions or poor operating results of underlying capital investments or intangible assets could result in losses or an inability to recover the carrying value of such assets, thereby possibly requiring an impairment charge in the future.

 

 

 

26



The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America.  The preparation of these financial statements requires us to make estimates, judgments and assumptions that we believe are reasonable based upon the information currently available.  These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented.  Any future changes to these estimates and assumptions could have a significant impact on the reported amounts of revenue, expenses, assets and liabilities in our financial statements.  The significant accounting policies which we believe are the most critical to aid in fully understanding and evaluating our reported financial results include the following:

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 (“SAB 104”), “Revenue Recognition in Financial Statements: Revenue Recognition, which states that revenue should be recognized when the following revenue recognition criteria are met:  (1) persuasive evidence of an arrangement exists; (2) the product has been shipped and the customer takes ownership and assumes the risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured.  The following policies apply to the Company’s major product sales categories for revenue recognition.

 

Sales to OEM Customers:  Revenue is recognized under the Company’s standard terms and conditions of sale, title and risk of loss transfer to the customer at the time products are shipped to the customer or the customers’ representative/freight forwarder (shipping terms Ex Works).  The Company has experienced minimal warranty or other returns and based upon historical experience, has recorded a $10,000 provision for such returns.

 

Sales to Distributors:  At certain times the Company provides certain incentives such as stock rotation, price protection and other incentives to its Distributors.  Therefore, under the sell through method of revenue recognition the Company defers recognition of revenue until such time that the distributor sells products to its customers based upon receipt of point-of-sale reports from the distributors. Distributor payments received before revenue is recognized is recorded as deferred revenue.  Unsold inventory held at distributor is included as a component of finished goods inventory.   See the Company’s adoption of the sell through method - Note 12 to the financial statements.

 

In addition, the Company records royalty revenue when earned in accordance with the underlying agreements which are based upon sales of products commercialized from the company’s licensed technology. Consulting revenue is recognized as services are performed in accordance with the terms of the underlying consulting agreements.

 

Accounts Receivable

 

The Company performs credit evaluations of customers and determines credit limits based upon payment history, customers’ credit worthiness and other factors, as determined by the Company’s review of their current credit information.  For a majority of the larger sales, the Company can require the issuance of a Letter of Credit.  Smaller accounts must either pay via credit card or in advance of shipment.  The Company continuously monitor collections and payments from customers, and maintains a provision for estimated credit losses based upon historical experience and any specific customer collection issues that have been identified.  While the Company has not had any significant credit losses to date, the Company cannot guarantee that it will continue to avoid credit losses in the future.  If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.  Since accounts receivable are highly concentrated in a small number of customers, a significant change in the liquidity or financial position of any one of these customers could have a material adverse impact on the collectibility of the Company’s accounts receivable, liquidity or future results of operations.  Receivables associated with deferred distributor revenue have been reclassed and an allowance for doubtful accounts is maintained to ensure trade receivables are recorded at net realizable value.  Accounts receivable may fluctuate but are expected to diminish as a result of selling the inventory related to the DDX business.

 

Inventory

 

Apogee states its inventory at the lower of cost (first-in, first-out) or marketThis policy requires that the Company make certain estimates regarding the market value of the inventory, including an assessment of excess or obsolete inventory.  The Company determines excess and obsolete inventory based on an estimated future demand and estimated selling prices for the Company’s products within a specified time frame, which is generally 12 months.  The estimates used for expected demand are also used for short-term capacity planning and inventory purchasing and are consistent with revenue forecasts. In addition to current inventory of approximately $1.8 million, net of reserve, consisting of approximately $800,000 held at Apogee and $1.0 million held at distributors, there are inventory purchase commitments of approximately $1.2 million at September 30, 2005.   This compares to inventory, net of reserves, of approximately $2.7 million consisting of approximately $1.5 million held at distributors with the remaining $1.2 million at Apogee at December 31, 2004.  The Company is in the process of selling off this inventory through existing and new channels, however this ability to sell may be limited as a result of a non-compete agreement associated with the sale of assets to SigmaTel. The Company is required to seek SigmaTel’s consent in connection with all such sales.  Actual demand and market conditions may be different from those projected by management.  If the unit demand forecast is less than current inventory value, the Company will be required to take additional excess

 

27



 

inventory charges or write-downs to net realizable value which will decrease the gross margin as well as the net operating results in the future.  During the three and nine months ended September 30, 2005, the Company recorded a provision for excess or obsolete inventory of approximately $255,000 and $576,000, respectively.  If actual market conditions are less than favorable than those projected by management, additional allowances may be required.  At September 30, 2005 approximately $400,000 of the $1.7million inventory reserve balance has been allocated against $1.2 million of non-cancelable purchase commitments.  Inventory for DDX parts will fluctuate but is expected to decrease over the next few quarters.

 

Valuation of Long-Lived Assets

 

Property, plant and equipment, patents, trademarks and other intangible assets are amortized over their estimated useful lives. Useful lives are based on management’s estimates over the period that such assets will generate revenue. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Future adverse changes in market conditions or poor operating results of underlying capital investments or intangible assets could result in losses or an inability to recover the carrying value of such assets, thereby possibly requiring an impairment charge in the future.

 

CERTAIN RISK FACTORS THAT MAY AFFECT FUTURE RESULTS OF OPERATIONS AND OUR COMMON STOCK PRICE

 

There are a number of important factors that could cause our actual results to differ materially from those indicated or implied by forward-looking statements. Factors that could cause or contribute to such differences include those discussed below, as well as those discussed elsewhere in this Form 10-QSB. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except as may be required by law.

 

RISKS RELATED TO OUR BUSINESS

 

WE HAVE HAD A HISTORY OF LOSSES, EXPECT FUTURE LOSSES AND MAY NEVER ACHIEVE OR SUSTAIN PROFITABILITY.

 

As of September 30, 2005, the Company had a stockholder deficiency of $2.1 million and had an accumulated deficit of approximately $20.3 million and working capital deficiency of approximately $2.4 million.  The Company recorded a loss of approximately $1.6 million and $4.6 million for the three- and  nine-month periods ended September 30, 2005.  The Company recorded a net loss of approximately $3.4 million for the year ended December 31, 2004 and a restated net loss of approximately $270,000 in 2003.  The Company will need to generate revenue to achieve and sustain profitability and positive cash flow.  The Company’s ability to generate future revenue and achieve and sustain profitability will depend on a number of factors, many of which are described throughout this risk factor section.  If we are unable to achieve and sustain profitability, the Company’s share price would likely decline.

 

 

THE COMPANY HAS ONLY A SMALL NUMBER OF CUSTOMERS, AND THE LOSS OF ANY OF THESE CUSTOMERS WOULD HAVE A MATERIAL ADVERSE EFFECT ON THE COMPANY’S BUSINESS.

 

During the nine months ended September 30, 2005, the Company derived approximately 68% of its total revenue and 66% of product revenue from four and three customers, respectively.  The loss of any of the Company’s customers, or a significant decrease in the amount of revenue generated from any of these customers, would have a material adverse effect on its business, financial condition and results of operations.  The Company is developing new customers and markets in order to diversify the market applications of its products.

 

WE WILL NEED TO RAISE ADDITIONAL CAPITAL OR SELL ASSETS IN ORDER TO CONTINUE TO PERFORM RESEARCH AND DEVELOPMENT AND OPERATE OUR BUSINESS, AND SUCH TRANSACTIONS MAY NOT BE AVAILABLE TO US ON FAVORABLE TERMS IF AT ALL.

 

Because we have historically had losses and only a limited amount of cash has been generated from operations, we have funded our operating activities to date primarily from the sale of securities. In order to continue to fund the development of our business, we will need additional capital, either through the sale of securities or through the sale of assets. We cannot be certain that any such financing or asset sales will be available on acceptable terms, or at all. Moreover, additional equity financing, if available, would likely be dilutive to the holders of our common stock, and debt financing, if available, would likely involve restrictive covenants. If we sell assets that are currently used in the conduct of our business, those assets would no longer be available to us as a potential source of revenue generation, as is the case with the October 5, 2005 sale of assets. If we cannot raise sufficient additional capital through means available to us, it would adversely affect our ability to achieve our business objectives.

 

 

28



 

NEITHER OUR DISCLOSURE CONTROLS AND PROCEDURES NOR OUR INTERNAL CONTROL OVER FINANCIAL REPORTING CAN PREVENT ALL ERRORS OR FRAUD, AND IN THE PAST THESE CONTROLS AND PROCEDURES WERE NOT EFFECTIVE AND RESULTED IN RESTATEMENTS TO OUR FINANCIAL RESULTS.

 

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be attained. Furthermore, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in a cost-effective control system, no evaluation of controls can provide absolute assurance that all misstatements due to error or fraud, if any, may occur and not be detected on a timely basis. These inherent limitations include the possibility that judgments in decision-making can be faulty and that breakdowns can occur because of errors or mistakes. Our controls and procedures can also be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Furthermore, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. While we seek to design our controls and procedures to provide reasonable assurance that information required to be disclosed in our periodic filings is timely disclosed, these inherent limitations expose us to breakdowns in such controls and procedures. For example, while our certifying officers believed that the design of our controls and procedures would ensure that material information related to the Company would be made known to them on a timely basis, in light of the circumstances underlying the Restatement, these controls and procedures for the financial statement periods covered by the Restatement were not effective. We have made certain changes to our internal control over financial reporting that are designed to address these circumstances, although even these improvements to our controls and procedures cannot ensure that all errors or fraud will be prevented.

 

OUR BUSINESS IS CONCENTRATED IN A LIMITED NUMBER OF MARKETS AND ANY SIGNIFICANT CHANGE IN THESE MARKETS COULD HAVE A MATERIAL ADVERSE EFFECT ON THE COMPANY’S BUSINESS.

 

Approximately 74% and 12% of the Company’s total revenue for the nine months ended September 30, 2005 were to customers in Asia and Europe, respectively.  All of the Company’s revenue was generated in the audio business, 88% of product revenue was from customers in Asia.  Prior to the sale of certain of its assets to SigmaTel, Inc., a significant percentage of the Company’s product revenue was to manufacturers producing DVD Receivers.  The Company will need to develop new markets and look to new sales channels in order to effectively market applications of its products. 

 

OUR MARKETS ARE SUBJECT TO RAPID TECHNOLOGICAL CHANGE AND, THEREFORE, OUR SUCCESS DEPENDS ON OUR ABILITY TO INTRODUCE NEW PRODUCTS IN A TIMELY FASHION.

 

The life cycle of the technology and any future products developed by us may be limited by the emergence of new products and technologies, changes in consumer preferences and other factors.  Our future performance will depend on our ability to consistently:

 

                                          identify emerging technological trends in our market;

 

                                          identify changing consumer requirements;

 

                                          develop or maintain competitive technology, including new product offerings;

 

                                          improve the performance, features and reliability of our products, particularly in response to technological change and competitive offerings;

 

                                          bring technology to market quickly at cost-effective prices, and

 

                                          protect our intellectual property.

 

 

We may not succeed in developing and marketing new products that respond to technological and competitive developments and changing customer needs, or and such products may not gain market acceptance and be incorporated into the technology or products of third parties.  Any significant delay or failure to develop new enhanced technologies, including new product offerings, and any failure of the marketplace to accept any new technology and product offerings would have a material adverse effect on our business, financial condition and results of operations.

 

 

29



 

OUR ABILITY TO ACHIEVE OR SUSTAIN REVENUE GROWTH WILL BE HARMED IF WE ARE UNABLE TO FIND NEW LICENING RELATIONSHIPS OR MAINTAIN OUR EXISTING LICENSING RELATIONSHIPS.

 

Part of our business strategy has been to expand our licensing activities with STMicroelectronics and to enter into licensing relationships with other companies in order to offer products to a larger customer base than could be reached through our own development and marketing efforts.  These have primarily been with our audio division.  We have believed that such relationships can accelerate market penetration of our products and technologies, while limiting our manufacturing exposure and sales and marketing costs.  However, we no longer own the assets associated with our audio division, therefore, may not be able to expand or maintain our existing licensing relationships or establish new licensing relationships on commercially reasonable terms, if at all.  Any future inability by us to maintain our licensing relationships or to enter into additional licensing relationships, or the failure of one or more of our licensing relationships to contribute to the development and maintenance of a market for our products, could have a material adverse effect on our business, operating results and financial condition.

 

OUR QUARTERLY OPERATING RESULTS MAY FLUCTUATE.

 

We have changed our primary line of business, we will experience fluctuations in our quarterly operating results as we have in the past and it is likely that these fluctuations will continue in the future.  These fluctuations are caused by many factors, including, but not limited to:

 

                                            availability and pricing from our suppliers;

 

                                            changes in the demand for our products by customers;

 

                                            introductions or enhancements of products, or delays in the introductions or enhancements of products, by us or our competitors;

 

                                            rate and success of new customer development;

 

                                            changes in our pricing policies or those of our competitors;

 

                                            success in attracting, retaining and motivating qualified personnel;

 

                                            changes in general economic conditions; and

 

                                            obsolescence of inventory.

 

A substantial portion of our operating expenses is related to personnel, facilities, and sales and marketing programs and are fixed.  Our expense level is based in part on our expectations of future orders and sales, which are extremely difficult to predict.  Accordingly, we may not be able to adjust our fixed expenses quickly enough to address any significant shortfall in demand for our products in relation to our expectations.

 

Fluctuations in our operating results may also result in fluctuations in our common stock price.  In such event, the trading price of our common stock would likely suffer and adversely affect our ability to raise capital and the value of your investment in the Company.

 

WE HAVE RECENTLY REDUCED OUR WORKFORCE CONSIDERABLY, IF WE ARE UNABLE TO HIRE OR RETAIN KEY PERSONNEL, WE MAY NOT BE ABLE TO OPERATE OUR BUSINESS SUCCESSFULLY.

 

We may not be successful in recruiting and retaining executive officers and other key management and technical personnel.  The competition for employees with the necessary high level of technical expertise to design, market and sell our products is intense, particularly in eastern Massachusetts and Asia.  As a result of the October 5, 2005 sale of certain assets to SigmaTel, Inc., will need to hire a number of additional technical personnel if we are sustain the development of new products and our ability to sell those products.  Because competition for highly skilled technical personnel is so intense, companies in Apogee’s industry are subject from time to time to complaints brought by competitors alleging interference with contractual relations or wrongful hiring of employees.  Such lawsuits may be costly, may divert management attention and resources from the operation of our business, and may therefore adversely affect our financial condition and results of operations.  In addition, the loss of the management and technical expertise of our senior management could seriously harm us.  Our employees may also be recruited away from us by our competitors.  The Company does not have in place employment contracts for some members of its senior management, including the CFO, COO and Vice President of Engineering.

 

30



 

 

THERE IS A NEW EUROPEAN DIRECTIVE TO ELIMINATE HAZARDOUS MATERIALS IN ELECTRONIC PRODUCTS AND AS SUCH WE MAY NOT BE ABLE TO TRANSITION OUR IC PRODUCTS TIMELY TO MEET CUSTOMER NEEDS AND MAY HAVE INVENTORY THAT CAN ONLY BE SOLD IN LIMITED MARKETS.

 

The IC industry is responding to the European directive of Restriction of Hazardous Substances (“RoHS”) that will become effective in July 2006.  As a result of this directive, semiconductor companies are working to remove lead and other hazardous materials used in their IC products. The Company expects to transition all of its IC products to conform to the RoHS standard during the first half of 2005. However, the Company may not be able to meet customer delivery requirements to support the 2005 consumer electronic design cycle. In addition, the Company currently has inventory to support European customers that may have to be sold in other markets.  Any excess inventory may not be able to be sold timely or at all.

 

WE DO NOT HAVE MANUFACTURING CAPABILITIES, AND AS A RESULT, WE RELY ON OUTSIDE FOUNDRIES TO MANUFACTURE OUR SILICON BASED PRODUCTS.

 

We have no manufacturing capabilities, nor do we have plans to establish any such capabilities.  Accordingly, we utilize outside semiconductor foundries, assembly and test companies to manufacture our silicon based products.  There are significant risks associated with our reliance on these foundries that can adversely affect our business, operating results and financial condition.  These risks include:

 

                                          the ability to maintain foundry relationships, the failure of which could result in significant delays in  product introduction due to the time necessary to establish new relationships;

 

                                          delays in production or shortages in product delivery as a result of production problems at outsidecontractors;

 

                                          the loss of foundry priority that may limit our ability to obtain products on schedule;

 

                                          limited control over product quality that could result in product returns and the loss of customers;

 

                                            inability to control manufacturing yield that could increase production costs, thereby reducing sales potential and operating margins; and

 

                                            lack of access or control over new process and manufacturing technologies to maintain product competitiveness in the market.

 

OUR PRODUCTS USE NEW TECHNOLOGY AND MAY HAVE MANUFACTURING DEFECTS OR OTHER CHARACTERISTICS THAT ARE ONLY DETECTED AFTER INSTALLATION IN CUSTOMER APPLICATIONS, WHICH MAY HARM OUR BUSINESS.

 

Our products are based on recently developed technology and are manufactured using state-of-the-art manufacturing processes.  Our approach to product qualification and testing may not fully evaluate or identify product characteristics or defects that could adversely affect the product’s ability to operate in the intended application.  If such defects or characteristics are discovered after installation, product revenue might be significantly delayed and our ability to maintain existing customers and to retain new customers may be seriously affected.

 

OUR ABILITY TO ACHIEVE REVENUE GROWTH WILL BE HARMED IF WE ARE UNABLE TO PERSUADE THE MARKET TO ADOPT OUR TECHNOLOGIES.

 

We face challenges in persuading manufacturers to adopt our products using MEMS technologies.  In order to adopt our products, manufacturers and engineers must understand and accept our new technology.  In addition, MEMS technologies may be more expensive or difficult to implement for some applications than traditional technologies.  For these reasons, prospective customers may be reluctant to adopt our technology.

 

INTENSE COMPETITION IN THE MEMS INDUSTRY COULD PREVENT US FROM ACHIEVING PROFITABILITY.

 

The MEMS industry is highly competitive, and we expect the intensity of the competition to increase. Many of our competitors have greater financial, technical, research, marketing, sales, distribution, service and other resources than we do.  Moreover, our competitors may offer broader product lines and have greater name recognition than we do, and may offer discounts as a competitive tactic, forcing intense pricing pressure on our products.  In addition, several development stage companies are currently creating or

 

 

31



 

developing technologies and products that compete with or are being designed to compete with our technologies and products.  Our competitors may develop or market technologies or products that are more effective or more commercially attractive than our current or future products, or that may render our technologies or products less competitive or obsolete.  Accordingly, if competitors introduce superior technologies or products and we cannot make enhancements to our technologies and products necessary for them to remain competitive, our competitive position, and in turn, our business, revenues and financial condition, will be seriously harmed.

 

OUR BUSINESS WILL SUFFER IF WE EXPERIENCE DIFFICULTIES IN INTEGRATING ANY TECHNOLOGIES, PRODUCTS OR BUSINESSES WE ACQUIRE.

 

In May 2004, the Company acquired the intellectual property and other intangibles and hired staff from Standard MEMS, Inc. Acquisitions typically entail many risks and could result in difficulties in integrating the operations and personnel of companies that we acquire or the technologies and products that we acquire. If we are not able to successfully integrate our acquisitions, we may not obtain the advantages that the acquisitions were intended to create, which could adversely affect our results of operations, financial condition and cash flows. In addition, in connection with acquisitions, we could experience disruption in our business or employee base. There is also a risk that key employees of companies that we acquire or key employees necessary to successfully commercialize technologies and products that we acquire may seek employment elsewhere, including with our competitors.

 

RISKS RELATED TO OUR INTELLECTUAL PROPERTY

 

OUR INTELLECTUAL PROPERTY AND PROPRIETARY RIGHTS MAY BE INSUFFICIENT TO PROTECT OUR COMPETITIVE POSITION.

 

Our business depends, in part, on our ability to protect our intellectual property.  We rely primarily on patent, copyright, trademark and trade secret laws to protect our proprietary technologies.  We cannot be sure that such measures will provide meaningful protection for our proprietary technologies and processes.  We have acquired a portfolio of MEMS intellectual property and the Company is reviewing this portfolio to determine which of the acquired rights will be most useful in its business.  We cannot be sure that any existing or future patents will not be challenged, invalidated or circumvented, or that any rights granted thereunder would provide us meaningful protection.  The failure of any patents to provide protection to our technology would make it easier for our competitors to offer similar products.

 

We also generally enter into confidentiality agreements with our employees and strategic partners, and generally control access to and distribution of our documentation and other proprietary information.  Despite these precautions, it may be possible for a third party to copy or otherwise obtain and use our products or technology without authorization, develop similar technology independently or design around our patents.  In addition, effective copyright, trademark and trade secret protection may be unavailable or limited in certain foreign countries in which we operate.

 

WE MAY BE SUBJECT TO INTELLECTUAL PROPERTY RIGHTS DISPUTES WHICH THAT COULD DIVERT MANAGEMENT’S ATTENTION AND COULD BE COSTLY.

 

The industries are characterized by vigorous protection and pursuit of intellectual property rights. From time to time, we may receive notices of claims of infringement, misappropriation or misuse of other parties’ proprietary rights. We cannot be sure that we will prevail in these actions, or that other actions alleging infringement by us of third-party patents, misappropriation or misuse by us of third-party trade secrets or the invalidity of one or more patents held by us will not be asserted or prosecuted against us, or that any assertions of infringement, misappropriation or misuse or prosecutions seeking to establish the invalidity of our patents will not seriously harm our business.  For example, in a patent or trade secret action, an injunction could be issued against us requiring that we withdraw particular products from the market or necessitating that specific products offered for sale or under development be redesigned.

 

Irrespective of the validity or successful assertion of various claims of infringement, misappropriation or misuse of other parties’ proprietary rights, we would likely incur significant costs and diversion of our management and personnel resources with respect to the defense of such claims, which could seriously harm our business.  If any claims or actions are asserted against us, we may seek to obtain a license under a third party’s intellectual property rights.  We cannot be sure that under such circumstances a license would be available on commercially reasonable terms, if at all.  Moreover, we often incorporate the intellectual property of our strategic customers into our designs, and we have certain obligations with respect to the non-use and non- disclosure of such intellectual property.  We cannot be sure that the steps taken by us to prevent our or our customers’, misappropriation or infringement of the intellectual property will be successful.

 

 

32



 

RISKS RELATING TO OUR COMMON STOCK

 

FACTORS UNRELATED TO OUR BUSINESS COULD NEGATIVELY IMPACT THE MARKET PRICE OF OUR COMMON STOCK.

 

The stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many technology companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. We expect that the market price of our Common Stock will fluctuate as a result of variations in our quarterly operating results, or for other reasons that are not related to the performance of our business. These fluctuations may be exaggerated if the trading volume of our Common Stock is low. In addition, due to the technology-intensive nature of our business, the market price for our Common Stock may rise and fall in response to various factors, including:

 

                                          announcements of technological innovations or new products, or competitive developments;

 

                                          investor perceptions and expectations regarding our or our competitors’ products;

 

                                          acquisitions or strategic alliances by us or our competitors, and

 

                                          the gain or loss of a significant customer or order.

 

In addition, market fluctuations, as well as general economic, political and market conditions such as recessions, interest rate changes or international currency fluctuations, may negatively impact the market price of our Common Stock.

 

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company’s financial instruments include: cash, cash equivalents, accounts receivable and accounts payable.  At September 30, 2005, the carrying value of the Company’s cash, cash equivalents, accounts receivable and accounts payable approximate fair values given the short maturity of these instruments.

 

Although the Company’s sales are predominately to international markets, the Company believes that it does not have material foreign currency exchange rate risk since international sales are in U.S. dollars and material purchases from foreign suppliers are typically also denominated in U.S. dollars.   Additionally, the functional currency of the Company’s foreign sales offices is the U.S. dollar.

 

It is the Company’s policy not to enter into derivative financial instruments for speculative purposes.

 

ITEM 4 — CONTROLS AND PROCEDURES

 

(a)          Evaluation of Disclosure Controls and Procedures.  The Company’s chief executive officer and principal financial officer have reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13d-15 (e) and 15d-15 (e)) as of the end of the period covered by this quarterly report.  Based on that evaluation, the chief executive officer and principal financial officer have concluded that the Company’s current disclosure controls and procedures are adequate and effective to ensure that material information relating to the Company was made known to them by others, particularly during the period in which this Quarterly Report on Form 10-QSB was being prepared.

 

(b)         Changes in Internal Controls.  There were no changes in our internal control over financial reporting, identified in connection with the evaluation of such internal control that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1 — LEGAL PROCEEDINGS

 

In November 2004, Apogee commenced an action against National Hybrid, Inc. (Hybrid) in the United States District Court for the Eastern District of New York, claiming that as part of Hybrid’s procurement of the tangible assets from the secured lien holder of the bankrupt Standard MEMS, Inc. (SMI), Hybrid had inadvertently obtained copies of files, containing in part, the intangible assets purchased by Apogee in May of 2004 as part of its MEMS acquisition. In November 2004, the court directed Hybrid not to sell, destroy or otherwise dispose of these files.  In response, Hybrid filed a counterclaim in February 2005, stating that they were the owner of the files. The court has delayed any further actions on this matter until January 2006 since the parties are now working to resolve the issue.  The Company believes Hybrid’s claims are without merit. The Company expects to resolve this issue with Hybrid, now held in estate due to the death of the prior owner, in 2005, and further does not believe the resolution will be material to its business.

 

 

33



 

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

On August 11, 2005, the Company entered into agreements with Laurus Master Fund, Ltd., whereby the Company received $2.0 million in gross proceeds (with net proceeds of approximately $1.8 million) through the sale of a 120 day secured term note. In accordance with the terms of the note, the note was payable by the Company in cash during the first 120 days following the issuance of the note, and after the 120 day period it was payable in the amount of $62,500 per month in cash or convertible into the common stock, $0.01 par value per share, of the Company at a fixed conversion price of $1.05 per share. In connection with the financing, the Company paid certain costs and expenses of Laurus and has issued an immediately exercisable warrant with terms restricting exercise. The Laurus warrant provides for the purchase of 85,000 shares of common stock at a price of $1.22 per share. The warrant expires seven years after issuance. A finder for the transaction received a fee of 5% of the gross proceeds of the offering, together with a seven year warrant to purchase an aggregate of 8,500 shares of common stock immediately exercisable at a price of $1.22 per share. This offering was conducted as a private placement pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. With respect to the transaction with Laurus, the Company has entered into an agreement to register the common stock underlying the warrants and the common stock that may be received upon any conversion of the secured term note.  On October 5, 2005 proceeds from the SigmaTel transaction were used to repay the approximately $2.1 million owed to Laurus Master Fund, Ltd. as well as payment of certain expenses related to the transaction.

 

ITEM 3 —DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4 — SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

None.

 

ITEM 5 — OTHER INFORMATION

 

None.

 

ITEM 6 — EXHIBITS

 

(a)    Exhibits:

 

See Exhibit Index

 

 

34



 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

APOGEE TECHNOLOGY, INC.

 

 

Date: November 14, 2005

By: /s/ Herbert M. Stein

 

Title: Chairman of the Board,

 

President, Chief Executive Officer

 

(principal executive officer)

 

 

 

APOGEE TECHNOLOGY, INC.

 

 

Date: November 14, 2005

By: /s/ Paul J. Murphy

 

Name: Paul J. Murphy

 

Title: Chief Financial officer and Vice President of Finance

 

(principal financial officer and principal accounting officer)

 

 

 

 

35


 


 

FORM-10-QSB

SEPTEMBER 30, 2005

 

EXHIBIT INDEX

 

Exhibit

 

 

Number

 

Description

10.1*

 

Securities Purchase Agreement, by and between Apogee Technology, Inc. and Laurus Master Fund, Ltd., incorporated herein by reference from Exhibit 10.1 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.2

 

Master Security Agreement, by and between Apogee Technology, Inc. and Laurus Master Fund, Ltd., incorporated herein by reference from Exhibit 10.2 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.3

 

Form of Laurus Master Fund, Ltd. Warrant, incorporated herein by reference from Exhibit 10.3 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.4

 

Grant of Security Interest In Patents and Trademarks, by and between Apogee Technology, Inc. and Laurus Master Fund, Ltd., incorporated herein by reference from Exhibit 10.4 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.5

 

Registration Rights Agreement, by and between Apogee Technology, Inc. and Laurus Master Fund, Ltd., incorporated herein by reference from Exhibit 10.5 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.6

 

Form of Biscayne Capital Markets, Inc. Warrant, incorporated herein by reference from Exhibit 10.7 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.7

 

Secured Convertible Term Note, by and between Apogee Technology, Inc. and Laurus Master Fund, Ltd., incorporated herein by reference from Exhibit 10.7 to the Registrant’s Form 8K as filed on August 9, 2005 (File No. 001-10456).

 

 

 

10.8

 

Asset Purchase Agreement dated as of October 5, 2005, by and among SigmaTel, Inc., Apogee Technology, Inc., certain stockholders, and with respect to the provisions of Section 8.15 only, David B. Meyers, incorporated herein by reference from Exhibit 99.1 to the Registrant’s Form 8K as filed on October 7, 2005 (File No. 001-10456).

 

 

 

10.9

 

Escrow Agreement dated as of October 5, 2005, among SigmaTel, Inc., Apogee Technology, Inc., and Wells Fargo Bank, N.A., incorporated herein by reference from Exhibit 99.2 to the Registrant’s Form 8K as filed on October 7, 2005 (File No. 001-10456).

 

 

 

10.10

 

Indemnification Agreement dated as of October 5, 2005, among SigmaTel, Inc., Apogee Technology, Inc., Herbert M. Stein, H.M. Stein Associates, and Sheryl B. Stein. incorporated herein by reference from Exhibit 99.3 to the Registrant’s Form 8K as filed on October 7, 2005 (File No. 001-10456).

.

 

 

31.1

 

Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer Regarding Facts and Circumstances Relating to Exchange Act Filings.

 

 

 

31.2

 

Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings.

 

 

 

32.1

 

Statement Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer and Principal Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings.

 

 

 

 

Where a document is incorporated by reference from a previous filing, the exhibit number of the document in that previous filing is indicated in parentheses after the description of such document.

 

Certain confidential material contained in this document has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended.